Transcatheter Heart Valves - Medical Devices Pipeline Assessment, 2018

  • ID: 4580450
  • Report
  • 307 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Admedus Ltd
  • Carena Healthcare Ltd
  • Dura LLC
  • JenaValve Technology GmbH
  • MitrAssist Ltd.
  • SAS Cormove
  • MORE
Transcatheter Heart Valves - Medical Devices Pipeline Assessment, 2018

Summary

The Medical Devices sector report, “Transcatheter Heart Valves - Medical Devices Pipeline Assessment, 2018" provides an overview of Transcatheter Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transcatheter Heart Valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by The team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transcatheter Heart Valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Admedus Ltd
  • Carena Healthcare Ltd
  • Dura LLC
  • JenaValve Technology GmbH
  • MitrAssist Ltd.
  • SAS Cormove
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Transcatheter Heart Valves Overview

3 Products under Development
3.1 Transcatheter Heart Valves - Pipeline Products by Stage of Development
3.2 Transcatheter Heart Valves - Pipeline Products by Segment
3.3 Transcatheter Heart Valves - Pipeline Products by Territory
3.4 Transcatheter Heart Valves - Pipeline Products by Regulatory Path
3.5 Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
3.6 Transcatheter Heart Valves - Ongoing Clinical Trials

4 Transcatheter Heart Valves - Pipeline Products under Development by Companies
4.1 Transcatheter Heart Valves Companies - Pipeline Products by Stage of Development
4.2 Transcatheter Heart Valves - Pipeline Products by Stage of Development

5 Transcatheter Heart Valves Companies and Product Overview
5.1 4C Medical Technologies Inc Company Overview
5.2 Admedus Ltd Company Overview
5.3 Aegis Surgical Limited Company Overview
5.4 Annulon Company Overview
5.5 AorTech International Plc Company Overview
5.6 AorTx, Inc. Company Overview
5.7 Arbor Surgical Technologies, Inc. Company Overview
5.8 Boston Children's Hospital Company Overview
5.9 Boston Scientific Corp Company Overview
5.10 Carena Healthcare Ltd Company Overview
5.11 Cephea Valve Technologies, Inc. Company Overview
5.12 Children's Hospital Boston Company Overview
5.13 Clemson University Company Overview
5.14 Colibri Heart Valve, LLC Company Overview
5.15 Daidalos Solutions BV Company Overview
5.16 Direct Flow Medical Inc (Inactive) Company Overview
5.17 DSM Dyneema BV Company Overview
5.18 Dura LLC Company Overview
5.19 Edwards Lifesciences Corp Company Overview
5.20 Emory University Company Overview
5.21 Endoluminal Technology Research, LLC Company Overview
5.22 Florida International University Company Overview
5.23 HighLife SAS Company Overview
5.24 HLT, Inc. Company Overview
5.25 JC Medical, Inc. Company Overview
5.26 JenaValve Technology GmbH Company Overview
5.27 LivaNova PLC Company Overview
5.28 Mayo Clinic Company Overview
5.29 Medtronic plc Company Overview
5.30 Meril Life Sciences Pvt Ltd Company Overview
5.31 Micro Interventional Devices, Inc. Company Overview
5.32 MicroPort Scientific Corp Company Overview
5.33 Mitralix Ltd. Company Overview
5.34 MitrAssist Ltd. Company Overview
5.35 MValve Technologies Ltd. Company Overview
5.36 NaviGate Cardiac Structures, Inc. Company Overview
5.37 Neovasc Inc Company Overview
5.38 PolyNova Cardiovascular LLC (Inactive) Company Overview
5.39 Polyvascular Corp Company Overview
5.40 RegenaGraft Company Overview
5.41 ReValve Med Inc Company Overview
5.42 SAS Cormove Company Overview
5.43 Sino Medical Sciences Technology Inc Company Overview
5.44 St. Jude Medical LLC Company Overview
5.45 Symetis SA Company Overview
5.46 Thubrikar Aortic Valve, Inc. Company Overview
5.47 Trinity College Dublin Company Overview
5.48 University College London Company Overview
5.49 University of California San Francisco Company Overview
5.50 University of Cambridge Company Overview
5.51 University of Iowa Company Overview
5.52 Valtech Cardio Ltd Company Overview
5.53 Vascular Concepts Ltd Company Overview
5.54 Venus MedTech Company Overview
5.55 Xeltis AG Company Overview

6 Transcatheter Heart Valves- Recent Developments
6.1 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value
6.2 May 31, 2018: JC Medical Announces First-in-Human Treatment with the Unique Transfemoral J-Valve TAVI Device for Aortic Regurgitation
6.3 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.4 May 22, 2018: Treatment with Abbott s Portico Transcatheter Aortic Valve Showed Portico is Safe and Reduces Severe Aortic Stenosis at 30 Days in Real-World Setting
6.5 May 22, 2018: Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards SAPIEN 3 Valve
6.6 May 22, 2018: Admedus: TAVR Progress Continues With Filing of New Provisional Patents
6.7 May 21, 2018: Edwards Announces Key Events For EuroPCR 2018
6.8 May 21, 2018: NaviGate Cardiac Structures reports “excellent valvular function” at 1-year follow-up of first patient to receive GATE tricuspid valved stent via transjugular access
6.9 May 17, 2018: MicroPort CardioFlow Releases One-year Clinical Outcome of VitaFlow
6.10 May 17, 2018: MicroPort CardioFlow Attends Fourth China Valve (Hangzhou) Meeting
6.11 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC
6.12 May 16, 2018: Boston Scientific Announces Schedule of Presentations at EuroPCR 2018
6.13 May 16, 2018: Boston Scientific Announces Schedule of Presentations at EuroPCR 2018
6.14 May 10, 2018: Neovasc Announces Results for the First Quarter 2018
6.15 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.16 May 04, 2018: Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System
6.17 Apr 26, 2018: Two-Year Feasibility Study Results Encouraging with Medtronic Harmony Transcatheter Pulmonary Valve
6.18 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.19 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results
6.20 Apr 19, 2018: Admedus TAVR Gaining Momentum With New Patent Applications
6.21 Apr 10, 2018: Jena Valve Technology Continues CE Mark Study Treating Severe Aortic Stenosis with Next-Generation System; Patient Enrollment and Successful Implantations with the Everdur Pericardial Aortic Valve and Coronatix Delivery Catheter
6.22 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.23 Mar 28, 2018: Boston Scientific Prevails In U.K. Edwards Lifesciences Litigation
6.24 Mar 28, 2018: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017
6.25 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results
6.26 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results
6.27 Mar 23, 2018: Edwards Prevails In U.S. Patent Office Review That Finds Boston Scientific Transcatheter Valve Patent Claims Invalid
6.28 Mar 23, 2018: JenaValve Technology Appoints Keith D Dawkins MD as Board Member
6.29 Mar 19, 2018: Colibri Heart Valve Advances Second-Generation TAVI System into Clinical Feasibility Study
6.30 Mar 12, 2018: Admedus TAVR Project Passes Testing Milestone
6.31 Mar 10, 2018: Clinical Trials Show Strong Long-Term Performance with the Medtronic CoreValve TAVR System
6.32 Mar 07, 2018: 4C Medical's Transcatheter Mitral Valve Technology Receives First Place in Cardiovascular Research Technologies 2018 Competition
6.33 Mar 01, 2018: 4C Medical's Novel Mitral Regurgitation Therapy to be Highlighted at CRT 2018 Meeting
6.34 Feb 28, 2018: First Oregonian receives artificial mitral heart valve without open-heart surgery
6.35 Feb 21, 2018: NaviGate Cardiac Structures reports GATE bioprosthesis as the first transcatheter valve replacement in Canada to treat tricuspid regurgitation
6.36 Feb 15, 2018: Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark
6.37 Feb 08, 2018: First Canadian Medicine: a 10th Case of Tricuspid Replacement Percutaneous in the World Achieved at the Institute
6.38 Feb 07, 2018: Polyvascular Aims To Manufacture Tiny Valves For Heart Valve Replacement
6.39 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove
6.40 Feb 02, 2018: JenaValve Technology Appoints Laura A Brenton as Vice President of Clinical and International Market Development
6.41 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.42 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results
6.43 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.44 Jan 22, 2018: Neovasc Appoints Fred Colen As Chief Executive Officer
6.45 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.46 Jan 08, 2018: MicroPort CardioFlow Attends 2017 PCR-CIT China Chengdu Valves
6.47 Jan 08, 2018: Neovasc Reports Tiara's Clinical Case Load Accelerating

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Transcatheter Heart Valves - Pipeline Products by Stage of Development
Table 2: Transcatheter Heart Valves - Pipeline Products by Segment
Table 3: Transcatheter Heart Valves - Pipeline Products by Territory
Table 4: Transcatheter Heart Valves - Pipeline Products by Regulatory Path
Table 5: Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
Table 6: Transcatheter Heart Valves - Ongoing Clinical Trials
Table 7: Transcatheter Heart Valves Companies - Pipeline Products by Stage of Development
Table 8: Transcatheter Heart Valves - Pipeline Products by Stage of Development
Table 9: 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: AltaValve - Product Status
Table 11: AltaValve - Product Description
Table 12: Admedus Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Transcatheter Aortic Valve Replacement Device - Product Status
Table 14: Transcatheter Aortic Valve Replacement Device - Product Description
Table 15: Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 16: pTAo-TAVR - Product Status
Table 17: pTAo-TAVR - Product Description
Table 18: Annulon Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Mitral Valve Replacement Device - Product Status
Table 20: Mitral Valve Replacement Device - Product Description
Table 21: AorTech International Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: AorTech Polymer Valve - Product Status
Table 23: AorTech Polymer Valve - Product Description
Table 24: AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 25: AorTx Valve - Product Status
Table 26: AorTx Valve - Product Description
Table 27: Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Trilogy Aortic Valve System - Product Status
Table 29: Trilogy Aortic Valve System - Product Description
Table 30: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Pulmonary Valve Replacement Device - Product Status
Table 32: Pulmonary Valve Replacement Device - Product Description
Table 33: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 34: ACURATE TAVR - Product Status
Table 35: ACURATE TAVR - Product Description
Table 36: Gen 4 Lotus Valve System - Product Status
Table 37: Gen 4 Lotus Valve System - Product Description
Table 38: Lotus Edge Sheath 15F - Product Status
Table 39: Lotus Edge Sheath 15F - Product Description
Table 40: Lotus Edge Valve System - 21 mm - Product Status
Table 41: Lotus Edge Valve System - 21 mm - Product Description
Table 42: Lotus Edge Valve System - 23 mm - Product Status
Table 43: Lotus Edge Valve System - 23 mm - Product Description
Table 44: Lotus Edge Valve System - 25 mm - Product Status
Table 45: Lotus Edge Valve System - 25 mm - Product Description
Table 46: Lotus Edge Valve System - 27 mm - Product Status
Table 47: Lotus Edge Valve System - 27 mm - Product Description
Table 48: Lotus Edge Valve System - 29 mm - Product Status
Table 49: Lotus Edge Valve System - 29 mm - Product Description
Table 50: Lotus Valve System - 21 mm - Product Status
Table 51: Lotus Valve System - 21 mm - Product Description
Table 52: Lotus Valve System - 23 mm - Product Status
Table 53: Lotus Valve System - 23 mm - Product Description
Table 54: Lotus Valve System - 25 mm - Product Status
Table 55: Lotus Valve System - 25 mm - Product Description
Table 56: Lotus Valve System - 27 mm - Product Status
Table 57: Lotus Valve System - 27 mm - Product Description
Table 58: Lotus Valve System - 29 mm - Product Status
Table 59: Lotus Valve System - 29 mm - Product Description
Table 60: Transaortic Sheath - Product Status
Table 61: Transaortic Sheath - Product Description
Table 62: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 63: Lotus Valve System - 23 mm - Experience with Percutaneous Transcatheter Aortic Valve Implantation in Patients with Symptomatic Aortic Valve Disease in Two German Centers
Table 64: Lotus Valve System - 23 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 65: Lotus Valve System - 23 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 66: Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
Table 67: Lotus Valve System - 23 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
Table 68: Lotus Valve System - 23 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 69: Lotus Valve System - 27 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 70: Lotus Valve System - 27 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 71: Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
Table 72: Lotus Valve System - 27 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
Table 73: Lotus Valve System - 27 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 74: Lotus Valve System - 25 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 75: Lotus Valve System - 25 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 76: Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in China: REPRISE China
Table 77: Lotus Valve System - 25 mm - Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System - Clinical Evaluation in Japan: REPRISE Japan
Table 78: Lotus Valve System - 25 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 79: Lotus Valve System - 21 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 80: Lotus Valve System - 21 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 81: Lotus Valve System - 21 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 82: Lotus Valve System - 29 mm - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 83: Lotus Valve System - 29 mm - Re-positionable Lotus Valve System - Post Market Evaluation of Real World Clinical Outcomes: RESPOND
Table 84: Lotus Valve System - 29 mm - Safety and Efficacy of Lotus Valve For Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis in Chinese Population (LOTUS-CHINA)
Table 85: Lotus Edge Valve System - 23 mm - Randomized Comparison of Repositionable and Balloon-Expandable Prostheses in Patients Undergoing Trans-catheter Aortic Valve Implantation

List of Figures
Figure 1: Transcatheter Heart Valves - Pipeline Products by Stage of Development
Figure 2: Transcatheter Heart Valves - Pipeline Products by Segment
Figure 3: Transcatheter Heart Valves - Pipeline Products by Territory
Figure 4: Transcatheter Heart Valves - Pipeline Products by Regulatory Path
Figure 5: Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
Figure 6: Transcatheter Heart Valves - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 4C Medical Technologies Inc
  • Admedus Ltd
  • Aegis Surgical Limited
  • Annulon
  • AorTech International Plc
  • AorTx, Inc.
  • Arbor Surgical Technologies, Inc.
  • Boston Children's Hospital
  • Boston Scientific Corp
  • Carena Healthcare Ltd
  • Cephea Valve Technologies, Inc.
  • Children's Hospital Boston
  • Clemson University
  • Colibri Heart Valve, LLC
  • Daidalos Solutions BV
  • Direct Flow Medical Inc
  • DSM Dyneema BV
  • Dura LLC
  • Edwards Lifesciences Corp
  • Emory University
  • Endoluminal Technology Research, LLC
  • Florida International University
  • HighLife SAS
  • HLT, Inc.
  • JC Medical, Inc.
  • JenaValve Technology GmbH
  • LivaNova PLC
  • Mayo Clinic
  • Medtronic plc
  • Meril Life Sciences Pvt Ltd
  • Micro Interventional Devices, Inc.
  • MicroPort Scientific Corp
  • Mitralix Ltd.
  • MitrAssist Ltd.
  • MValve Technologies Ltd.
  • NaviGate Cardiac Structures, Inc.
  • Neovasc Inc
  • PolyNova Cardiovascular LLC
  • Polyvascular Corp
  • RegenaGraft
  • ReValve Med Inc
  • SAS Cormove
  • Sino Medical Sciences Technology Inc
  • St. Jude Medical LLC
  • Symetis SA
  • Thubrikar Aortic Valve, Inc.
  • Trinity College Dublin
  • University College London
  • University of California San Francisco
  • University of Cambridge
  • University of Iowa
  • Valtech Cardio Ltd
  • Vascular Concepts Ltd
  • Venus MedTech
  • Xeltis AG
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll